The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be granted market authorization in the European Union, marking the first time ...

The European Medicines Agency (EMA) has recommended granting marketing authorization to the combined influenza and COVID-19 messenger RNA (mRNA) vaccine, mCombriax (Moderna), for people aged 50 years ...

Moderna’s mRNA-based combination vaccine against both flu and COVID-19 has gotten the green light in Europe—but it continues to be shelved in the US, where it was developed. This week, the European ...

Moderna said on Tuesday the European Commission had approved its combination vaccine for the ​prevention of influenza and ...

Starting this autumn, adults aged 50 and older across the European Union may be able to roll up their sleeve just once and walk away protected against both COVID-19 and influenza. The European ...

Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, according to published results.

European drug regulators recommended authorizing Moderna’s combined vaccine against Covid-19 and the flu, paving the way for the shot’s approval in the European Union at a time the company is facing ...

Over three-fourths of healthcare workers received an influenza vaccine in 2024-2025, survey data showed. COVID vaccination was less common, at 40%, but that represented a significant jump over the ...

A single spritz could eventually offer simultaneous protection against several infectious diseases. Researchers at Stanford Medicine have developed a new vaccine that could prevent multiple viruses at ...

The CDC's new immunization schedule reduces routine pediatric vaccines from 17 to 11, excluding COVID-19 for healthy children and pregnant women. RSV vaccination rates are low among adults over 75, ...